BL
Balentine LLC Portfolio holdings
AUM
$2.57B
This Quarter Return
-10.29%
1 Year Return
+11.26%
3 Year Return
+43.25%
5 Year Return
+72.63%
10 Year Return
+167.54%
AUM
$1.25B
AUM Growth
+$1.25B
(-12%)
Cap. Flow
+$26.9M
Cap. Flow
% of AUM
2.15%
Top 10 Holdings %
Top 10 Hldgs %
89.65%
Holding
498
New
132
Increased
105
Reduced
24
Closed
61
Top Buys
Top Sells
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
$158M |
| 2 |
Energy Select Sector SPDR Fund
XLE
|
$119M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$94.6M |
| 4 |
iShares Core S&P US Value ETF
IUSV
|
$92.4M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$61.6M |
Sector Composition
| 1 | Technology | 0.43% |
| 2 | Financials | 0.26% |
| 3 | Industrials | 0.25% |
| 4 | Consumer Staples | 0.24% |
| 5 | Healthcare | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
TSMC
TSM
$1.18T
| $30K | ﹤0.01% |
818
-480
| -37% | -$17.6K |
|
|
CHL
152
DELISTED
China Mobile Limited
CHL
| $30K | ﹤0.01% |
626
+495
| +378% | +$23.7K |
|
153
Telkom Indonesia
TLK
$18.7B
| $29K | ﹤0.01% |
1,108
+830
| +299% | +$21.7K |
|
154
TransUnion
TRU
$16.8B
| $29K | ﹤0.01% |
506
| – | – |
|
155
Broadridge
BR
$29.5B
| $28K | ﹤0.01% |
295
| – | – |
|
156
iShares Core S&P US Growth ETF
IUSG
$24.2B
| $28K | ﹤0.01% |
530
+219
| +70% | +$11.6K |
|
157
Procter & Gamble
PG
$370B
| $28K | ﹤0.01% |
307
+81
| +36% | +$7.39K |
|
158
Royal Bank of Canada
RY
$204B
| $28K | ﹤0.01% |
403
+246
| +157% | +$17.1K |
|
159
AT&T
T
$208B
| $28K | ﹤0.01% |
997
-242
| -20% | -$6.8K |
|
160
BCE
BCE
$22.8B
| $27K | ﹤0.01% |
694
| – | – |
|
161
Bunge Global
BG
$16.3B
| $27K | ﹤0.01% |
+500
| New | +$27K |
|
|
B
162
Barrick Mining Corporation
B
$45.9B
| $27K | ﹤0.01% |
1,988
+1,342
| +208% | +$18.2K |
|
163
Marsh & McLennan
MMC
$101B
| $27K | ﹤0.01% |
344
| – | – |
|
164
Waste Connections
WCN
$47B
| $27K | ﹤0.01% |
360
| – | – |
|
165
Duke Energy
DUK
$94.8B
| $26K | ﹤0.01% |
304
+75
| +33% | +$6.41K |
|
166
Energy Transfer Partners
ET
$60.8B
| $26K | ﹤0.01% |
+2,000
| New | +$26K |
|
167
GSK
GSK
$78.5B
| $26K | ﹤0.01% |
675
| – | – |
|
168
AstraZeneca
AZN
$249B
| $25K | ﹤0.01% |
647
| – | – |
|
169
Crown Castle
CCI
$42.7B
| $25K | ﹤0.01% |
226
+52
| +30% | +$5.75K |
|
170
PNC Financial Services
PNC
$80.9B
| $25K | ﹤0.01% |
211
| – | – |
|
171
Vanguard Total World Stock ETF
VT
$51.2B
| $25K | ﹤0.01% |
375
| – | – |
|
172
Ameriprise Financial
AMP
$48.3B
| $24K | ﹤0.01% |
233
| – | – |
|
173
Canadian Imperial Bank of Commerce
CM
$71.8B
| $24K | ﹤0.01% |
324
+99
| +44% | +$7.33K |
|
174
DuPont de Nemours
DD
$31.7B
| $24K | ﹤0.01% |
443
| – | – |
|
175
Merck
MRK
$214B
| $24K | ﹤0.01% |
312
| – | – |
|